NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.64
-1.67 (-10.91%)
At close: Jul 29, 2026, 4:00 PM EDT
13.91
+0.27 (1.98%)
After-hours: Jul 29, 2026, 7:49 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $465.04 million as of July 29, 2026. Its market cap has increased by 62.23% in one year.
Market Cap
465.04M
Enterprise Value
481.52M
1-Year Change
62.23%
Ranking
Category
Stock Price
$13.64
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $465.04M, an increase of 18.25%. That is a compound annual growth rate of 3.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 465.04M | -9.57% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 676.52M |
| Tactile Systems Technology | 625.71M |
| BrainsWay | 620.31M |
| Cerus | 585.08M |
| Cytek Biosciences | 575.98M |
| OrthoPediatrics | 509.59M |
| Orthofix Medical | 495.57M |
| Varex Imaging | 469.09M |